Now Available: Hypercholesterolemia Therapeutics - Pipeline Assessment and Market Forecasts to 2017

May 30, 2011 - PRLog -- Hypercholesterolemia Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis specialist, has released its new report, "Hypercholesterolemia Therapeutics - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global Hypercholesterolemia Therapeutics market. The report identifies the key trends shaping and driving the global Hypercholesterolemia Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Hypercholesterolemia Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/159603_hypercholesterolemia_th...
------------------------------------------------------------

Scope

* The report provides information on the key drivers and challenges of the Hypercholesterolemia Therapeutics market. Its scope includes:
* Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Hypercholesterolemia Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.
* Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
* Analysis of the current and future competition in the seven key countries Hypercholesterolemia Therapeutics market.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Hypercholesterolemia Therapeutics therapeutics market.
* Analysis of key recent licensing and partnership agreements in Hypercholesterolemia Therapeutics market


Reasons to buy

The report will enhance your decision making capability. It will allow you to -

* Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global Hypercholesterolemia Therapeutics market.
* Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Hypercholesterolemia Therapeutics market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What's the next big thing in the global Hypercholesterolemia Therapeutics market landscape? - Identify, understand and capitalize.


Partial Table of Contents:

1 Table of contents
1 Table of contents
1.1 List of Tables
1.2 List of Figures
2 Hypercholesterolemia: Introduction
2.1 Overview
2.2 Epidemiology
2.3 Etiology
2.4 Clinical Presentation/Symptoms
2.5 Prognosis
2.6 Diagnosis
2.6.1 Clinical
2.7 Pathophysiology
2.8 Treatment
2.8.1 Lifestyle changes
2.8.2 Medication
2.9 GlobalData Pipeline Report Guidance
3 Hypercholesterolemia Therapeutics Market: Market Characterization
3.1 Major Markets: Market Size (2005-2010)
3.2 Major Markets, Market Forecast (2010-2017)
3.3 The US, Market Size (2005-2010)
3.4 The US, Market Forecast (2010-2017)
3.5 The UK, Market Size (2005-2010)
3.6 The UK, Market Forecast (2010-2017)
3.7 Germany, Market Size (2005-2010)
3.8 Germany, Market Forecast (2010-2017)
3.9 France, Market Size (2005-2010)
3.10 France, Market Forecast (2010-2017)
3.11 Spain, Market Size (2005-2010)
3.12 Spain, Market Forecast (2010-2017)
3.13 Italy, Market Size (2005-2010)
3.14 Italy, Market Forecast (2010-2017)
3.15 Japan, Market Size (2005-2010)
3.16 Japan, Market Forecast (2010-2017)
3.17 Drivers and Barriers for the Hypercholesterolemia Therapeutics Market
3.17.1 Hypercholesterolemia Therapeutics Market Drivers
3.17.2 Hypercholesterolemia Market Barriers
3.18 Opportunity and Unmet Need
3.19 Key Takeaway
4 Hypercholesterolemia Therapeutics: Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profile for the Major Marketed Products in the Hypercholesterolemia Therapeutics Market
4.3.1 Lipitor (Atorvastatin)
4.3.2 Crestor (Rosuvastatin)
4.3.3 Niaspan (Nicotinic Acid)
4.3.4 Tricor (Fenofibrate)
4.4 Key Takeaway
5 Hypercholesterolemia Therapeutics: Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Hypercholesterolemia Therapeutics Market - Pipeline Analysis by Phase of Development
5.3.1 Hypercholesterolemia - Phase III Clinical Pipeline
5.3.2 Hypercholesterolemia Therapeutics Market - Phase II Clinical Pipeline
5.3.3 Hypercholesterolemia Therapeutics Market - Phase I Clinical Pipeline
5.3.4 Hypercholesterolemia Therapeutics Market - Preclinical Clinical Pipeline
5.3.5 Hypercholesterolemia Therapeutics Market - Discovery Clinical Pipeline

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=1596...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.  

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.